The DEA’s proposal would classify concentrated synthetic 7-OH products as Schedule I drugs, while leaving most botanical kratom outside the ban.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/dea-targets-synthetic-7-oh-products-schedule-i-proposal-2026a1000nfw?src=rss
Author :
Publish date : 2026-07-10 16:44:00
Copyright for syndicated content belongs to the linked Source.
